Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...
LONDON/COPENHAGEN (Reuters) -Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled ...
LAURA CRAIK looks into a new trend where designer brands are turning commonplace items into designer must-haves by slapping a ...
Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...
The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...
Novo Nordisk said Thursday that the rampant growth of the U.S.’ compounded drug industry was hurting Wegovy sales, and warned ...
LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since ...
Participants in the trend used an AI-driven tool, created by a user on the editing app CapCut, to alter themselves to look ...
Everything changed in 2020. Millions of Australians found themselves stuck inside – just as an ecosystem of ADHD content creators was flourishing on social media. The story of how CSIRO came to ...
Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
A 2022 study found that within a year of going off semaglutide, sold under the name brands Wegovy and Ozempic, participants regained an average of two-thirds of their lost weight. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results